(Q57265426)

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Differing acute phase responses in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

ESR or CRP? A comparison of their clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

"Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Factors associated with disease activity of pouchitis after surgery for ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

The value of serologic markers in indeterminate colitis: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Enzymes in feces: useful markers of chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

High prevalence of NSAID enteropathy as shown by a simple faecal test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Subclinical intestinal inflammation: an inherited abnormality in Crohn’s disease relatives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481

Lack of Association Between Genetic Variation in 9 Innate Immunity Genes and Baseline CRP Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.1.4.481